EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cancer-associated fibroblasts in non-small cell lung cancer therapy: Challenges and opportunities

Siyou Deng, Yu Li, Lin Peng, Jinjie Li, Li Zhang

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026

DOI: 10.1016/j.bbcan.2026.189568 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026. Verfasst von Siyou Deng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Cancer-Associated Fibroblasts, Lung Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 214 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related morbidity and mortality despite therapeutic advances. Current treatments offer limited benefit to many patients, a limitation closely linked to distinctive features of the tumor microenvironment (TME). As key components of the TME, cancer-associated fibroblasts (CAFs) promote a desmoplastic response, remodel the extracellular matrix, secrete cytokines, and directly shape tumor cell behavior. Consequently, therapeutic strategies targeting CAFs have attracted growing attention. However, due to substantial heterogeneity in CAF origin, definition, and function, combined with high plasticity, few therapeutic approaches targeting CAFs have proven effective; indeed, some interventions have paradoxically accelerated disease progression. This review examines CAF subsets in NSCLC and elucidates how CAFs influence the therapeutic efficacy of chemotherapy, radiotherapy, immunotherapy, and targeted therapy. Finally, we synthesize the translational progress of CAF-targeted strategies in NSCLC, emphasizing current limitations and future opportunities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungCancer-Associated FibroblastsLung NeoplasmsHumansTumor MicroenvironmentAnimalsImmunotherapy

Stichwörter der Autor:innen

Cancer-associated fibroblastsHeterogeneityNon-small cell lung cancerTherapy resistanceTumor microenvironment

Autor:innen und Institutionen

  • Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, China.
  • Department of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, China.
  • Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, China. Electronic address: 2008tj0544@hust.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Deng, S., Li, Y., Peng, L., Li, J., & Zhang, L. (2026). Cancer-associated fibroblasts in non-small cell lung cancer therapy: Challenges and opportunities. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2026.189568

Vancouver

Deng S, Li Y, Peng L, Li J, Zhang L. Cancer-associated fibroblasts in non-small cell lung cancer therapy: Challenges and opportunities. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026. doi:10.1016/j.bbcan.2026.189568

BibTeX
@article{Deng2026,
  author = {Deng, Siyou and Li, Yu and Peng, Lin and Li, Jinjie and Zhang, Li},
  title = {Cancer-associated fibroblasts in non-small cell lung cancer therapy: Challenges and opportunities},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2026},
  doi = {10.1016/j.bbcan.2026.189568}
}
Kostenlos starten →